Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia

NCT01890694 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01890694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01890694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2012
Completion date
March 31, 2015
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyponatremia